Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Review

Meta-Analysis

Clinical Trial

Randomized Controlled Trial

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2024

2017

2016

2015

2013

2012

2010

2009

2006

2005

2004

2003

2002

2001

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Tumor Protein p73""[mesh_terms]

18 Results

Searching titles within these results

Structural Evolution and Dynamics of the p53 Proteins.

Giovanni Chillemi, Sebastian Kehrloesser, Francesca Bernassola, Alessandro Desideri, Volker Dötsch, Arnold J Levine, Gerry Melino

Cold Spring Harbor perspectives in medicine 2017;7(4):a028308

Free Full Text

Abstract

Risk factors and remaining challenges in the treatment of acute promyelocytic leukemia.

Yasuhisa Yokoyama

International journal of hematology 2024;120(5):548-555

Full Text

Abstract

p53 protein variants: structural and functional similarities with p63 and p73 isoforms.

Stéphanie Courtois, Claude Caron de Fromentel, Pierre Hainaut

Oncogene 2004;23(3):631-8

Full Text

Abstract

P53 family: at the crossroads in cancer therapy.

Samar Alsafadi, Sophie Tourpin, Fabrice André, Gilles Vassal, Jean-Charles Ahomadegbe

Current medicinal chemistry 2010;16(32):4328-44

Full Text

Abstract

p73 G4C14-to-A4T14 gene polymorphism and interaction with p53 exon 4 Arg72Pro on cancer susceptibility: a meta-analysis of the literature.

Emma De Feo, Benedetto Simone, Rachel Simo Kamgaing, Paola Gallì, Nobuyuki Hamajima, Zhibin Hu, Guojun Li, Yan Li, Keitaro Matsuo, Jae Yong Park, Susanta Roychoudhury, Margaret R Spitz, Qingyi Wei, Jian-Hui Zhang, Walter Ricciardi, Stefania Boccia

Mutagenesis 2012;27(3):267-73

Full Text

Abstract

Association between TLR2, MTR, MTRR, XPC, TP73, TP53 genetic polymorphisms and gastric cancer: a meta-analysis.

Chen Cheng, Wang Lingyan, Huang Yi, Zhang Cheng, Ye Huadan, Xu Xuting, Xu Leiting, Ye Meng, Duan Shiwei

Clinics and research in hepatology and gastroenterology 2015;38(3):346-59

Full Text

Abstract

Methylation alterations at imprinted genes detected among long-term shiftworkers.

Daniel I Jacobs, Johnni Hansen, Alan Fu, Richard G Stevens, Anne Tjonneland, Ulla B Vogel, Tongzhang Zheng, Yong Zhu

Environmental and molecular mutagenesis 2013;54(2):141-6

Free Full Text

Abstract

High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia.

Antonio R Lucena-Araujo, Haesook T Kim, Carolina Thomé, Rafael H Jacomo, Raul A Melo, Rosane Bittencourt, Ricardo Pasquini, Katia Pagnano, Ana Beatriz F Glória, Maria de Lourdes Chauffaille, Melina Athayde, Carlos S Chiattone, Ingrid Mito, Rodrigo Bendlin, Carmino Souza, Cristina Bortolheiro, Juan L Coelho-Silva, Stanley L Schrier, Martin S Tallman, David Grimwade, Arnold Ganser, Nancy Berliner, Raul C Ribeiro, Francesco Lo-Coco, Bob Löwenberg, Miguel A Sanz, Eduardo M Rego

Blood 2016;126(20):2302-6

Free Full Text

Abstract

Analysis of p73 expression pattern in acute myeloid leukemias: lack of DeltaN-p73 expression is a frequent feature of acute promyelocytic leukemia.

M G Rizzo, E Giombini, D Diverio, M Vignetti, A Sacchi, U Testa, F Lo-Coco, G Blandino

Leukemia 2004;18(11):1804-9

Full Text

Abstract

Inhibition of damage-regulated autophagy modulator-1 (DRAM-1) impairs neutrophil differentiation of NB4 APL cells.

Magali Humbert, Chantal Mueller, Martin F Fey, Mario P Tschan

Leukemia research 2013;36(12):1552-6

Full Text

Abstract

Telomerase regulation at the crossroads of cell fate.

A Cukusić, N Skrobot Vidacek, M Sopta, I Rubelj

Cytogenetic and genome research 2009;122(3-4):263-72

Full Text

Abstract

Distinct TP73-DAPK2-ATG5 pathway involvement in ATO-mediated cell death versus ATRA-mediated autophagy responses in APL.

Magali Humbert, Elena A Federzoni, Mario P Tschan

Journal of leukocyte biology 2017;102(6):1357-1370

Full Text

Abstract

Regulation of telomerase activity by the p53 family member p73.

M Beitzinger, C Oswald, R Beinoraviciute-Kellner, T Stiewe

Oncogene 2006;25(6):813-26

Full Text

Abstract

Assessing TP53 status in human tumours to evaluate clinical outcome.

T Soussi, C Béroud

Nature reviews. Cancer 2002;1(3):233-40

Full Text

Abstract

Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.

Ugo Testa, Francesco Lo-Coco

Annals of hematology 2016;95(5):673-80

Full Text

Abstract

Results: 1 – 15 / 18

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Tumor Protein p73""[mesh_terms]

Structural Evolution and Dynamics of the p53 Proteins.

Risk factors and remaining challenges in the treatment of acute promyelocytic leukemia.

p53 protein variants: structural and functional similarities with p63 and p73 isoforms.

P53 family: at the crossroads in cancer therapy.

p73 G4C14-to-A4T14 gene polymorphism and interaction with p53 exon 4 Arg72Pro on cancer susceptibility: a meta-analysis of the literature.

Association between TLR2, MTR, MTRR, XPC, TP73, TP53 genetic polymorphisms and gastric cancer: a meta-analysis.

Methylation alterations at imprinted genes detected among long-term shiftworkers.

High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia.

Analysis of p73 expression pattern in acute myeloid leukemias: lack of DeltaN-p73 expression is a frequent feature of acute promyelocytic leukemia.

Inhibition of damage-regulated autophagy modulator-1 (DRAM-1) impairs neutrophil differentiation of NB4 APL cells.

Telomerase regulation at the crossroads of cell fate.

Distinct TP73-DAPK2-ATG5 pathway involvement in ATO-mediated cell death versus ATRA-mediated autophagy responses in APL.

Regulation of telomerase activity by the p53 family member p73.

Assessing TP53 status in human tumours to evaluate clinical outcome.

Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.

Results for
""Tumor Protein p73""[mesh_terms]